Xu KY - Search Results

1

Brain-Hazardous Medications and Potential Subadequate Antidepressant Dosing in Older Surgical Patients Receiving Home Antidepressants: An Observational Study of a Large US Health System.

Pennington BRT, Holzer KJ, Fritz BA, Haroutounian S, Xu KY, Tedder A, Kronzer A, Avidan MS, Lenze EJ. Pennington BRT, et al. Among authors: xu ky. Anesth Analg. 2024 Jul 1;139(1):155-164. doi: 10.1213/ANE.0000000000006952. Epub 2024 Mar 20. Anesth Analg. 2024. PMID: 38507476

2

Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People.

Xu KY, Jones HE, Schiff DM, Martin CE, Kelly JC, Carter EB, Bierut LJ, Grucza RA. Xu KY, et al. Obstet Gynecol. 2023 Apr 1;141(4):845-853. doi: 10.1097/AOG.0000000000005117. Epub 2023 Mar 9. Obstet Gynecol. 2023. PMID: 36897142 Free PMC article.

3

Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder.

Mintz CM, Xu KY, Presnall NJ, Hartz SM, Levin FR, Scherrer JF, Bierut LJ, Grucza RA. Mintz CM, et al. Among authors: xu ky. JAMA Netw Open. 2022 May 2;5(5):e2211634. doi: 10.1001/jamanetworkopen.2022.11634. JAMA Netw Open. 2022. PMID: 35544135 Free PMC article.

4

Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder: A Case-Crossover Analysis.

Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA. Xu KY, et al. J Clin Psychiatry. 2022 Jun 20;83(4):21m14112. doi: 10.4088/JCP.21m14112. J Clin Psychiatry. 2022. PMID: 35759785 Free PMC article.

5

Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015.

Xu KY, Hartz SM, Borodovsky JT, Bierut LJ, Grucza RA. Xu KY, et al. JAMA Netw Open. 2020 Dec 1;3(12):e2028557. doi: 10.1001/jamanetworkopen.2020.28557. JAMA Netw Open. 2020. PMID: 33295972 Free PMC article.

6

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.

Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA. Xu KY, et al. JAMA Netw Open. 2022 May 2;5(5):e2211363. doi: 10.1001/jamanetworkopen.2022.11363. JAMA Netw Open. 2022. PMID: 35536575 Free PMC article.

7

Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.

Xu KY, Presnall N, Mintz CM, Borodovsky JT, Bhat NR, Bierut LJ, Grucza RA. Xu KY, et al. JAMA Netw Open. 2021 Feb 1;4(2):e210061. doi: 10.1001/jamanetworkopen.2021.0061. JAMA Netw Open. 2021. PMID: 33625511 Free PMC article.

8

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.

Tardelli V, Xu KY, Bisaga A, Levin FR, Fidalgo TM, Grucza RA. Tardelli V, et al. Among authors: xu ky. BMJ Ment Health. 2023 Jul;26(1):e300728. doi: 10.1136/bmjment-2023-300728. BMJ Ment Health. 2023. PMID: 37500184 Free PMC article.

9

Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder.

Ellis MS, Xu KY, Tardelli VS, Fidalgo TM, Buttram ME, Grucza RA. Ellis MS, et al. Among authors: xu ky. JAMA Psychiatry. 2023 Dec 1;80(12):1269-1276. doi: 10.1001/jamapsychiatry.2023.3145. JAMA Psychiatry. 2023. PMID: 37672238

10

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims.

Xu KY, Huang V, Williams AR, Martin CE, Bazazi AR, Grucza RA. Xu KY, et al. Drug Alcohol Depend Rep. 2023 Oct 20;9:100195. doi: 10.1016/j.dadr.2023.100195. eCollection 2023 Dec. Drug Alcohol Depend Rep. 2023. PMID: 38023343 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page